Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

“D” Is for Diagnosis: The Radiologist's Role in Detecting and Diagnosing Rare Interstitial Lung Diseases

Release Date: August 31, 2020
Expiration Date: August 31, 2021

Activity Overview

This online, on-demand virtual symposium brings together a renowned group of experts on the diagnosis of interstitial lung diseases (ILDs). ILDs are a multifaceted group of lung disorders with similar clinical, physiologic, pathologic, and radiologic characteristics. In progressive or severe forms, ILDs lead to progressive loss of lung function, respiratory failure, decreased quality of life and early mortality. Although considered rare, the incidence of ILDs caused by either unknown causes or in association with other diseases or environmental exposures has increased along with more complex and expanding disease classification. During this highly interactive, game-style symposium, the audience is encouraged to examine ‘mystery’ cases, look for clues from the clinical history and presentation, evaluate radiologic imaging and other diagnostic test results, and ultimately uncover the correct diagnosis. Expert faculty reveal the underlying disease and review therapeutic options.

This educational activity is an archive of a live virtual symposium held on August 14, 2020.

Acknowledgment of Commercial Support.

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward radiologists, pulmonologists, pathologists, physician assistants, nurse practitioners, and additional health care professionals who are involved in the diagnosis of ILDs.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the pathophysiology of multiple ILD subtypes and identify how these mechanisms influence diagnostic signs, symptoms, and radiologic findings
  • Interpret radiographic patterns on high-resolution computed tomography (HRCT) to differentially diagnose ILDs
  • Evaluate efficacy and tolerability of new and emerging treatments for ILD subtypes and their potential use in clinical practice

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Ami N. Rubinowitz, MD
Ami N. Rubinowitz, MD
Associate Professor of Radiology and Biomedical Imaging
Yale School of Medicine and Thoracic Imaging Section
Yale New Haven Hospital
Thoracic Radiologist, Department of Radiology and Biomedical Imaging
Bridgeport Hospital, Yale New Haven Health
New Haven, CT

Disclosures: Ami N. Rubinowitz, MD has no relevant financial relationships with commercial interest to disclose.

Jonathan H. Chung, MD
Jonathan H. Chung, MD
Professor of Radiology
Vice Chair of Quality and Section Chief
Cardiopulmonary Imaging
The University of Chicago
Chicago, IL

Disclosures: Jonathan H. Chung, MD has no relevant financial relationships with commercial interest to disclose.

Michael Kadoch, MD
Michael Kadoch, MD
Assistant Professor
Chief, Cardiothoracic Radiology
University of California, Davis Medical Center
Sacramento, CA

Disclosures: Speakers Bureau: Boehringer Ingelheim

Lisa H Lancaster, MD
Lisa H Lancaster, MD
Associate Professor of Medicine
Director, Interstitial Lung Disease Program
Vanderbilt University Medical Center
Nashville, TN

Disclosures: Grant Research Support: Bellerophon Therapeutics, Novartis, Celgene, Galecto Biotech, Respirant Pharma, Biogen, Bristol Myers Squibb, Boehringer-Ingelheim, FibroGen, Galapagos NV, Piront; Consultant: Galapagos Biotech, United Therapeutics, Bristol Myers Squibb; Speakers Bureau: Genentech, Boehringer Ingelheim; Other: Spouse is an employee of Medtronic.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By